1. Home
  2. AKBA vs RELL Comparison

AKBA vs RELL Comparison

Compare AKBA & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

N/A

Current Price

$0.57

Market Cap

248.3M

Sector

Health Care

ML Signal

N/A

Logo Richardson Electronics Ltd.

RELL

Richardson Electronics Ltd.

N/A

Current Price

$20.08

Market Cap

248.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
AKBA
RELL
Founded
2007
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
248.3M
248.1M
IPO Year
2014
2004

Fundamental Metrics

Financial Performance
Metric
AKBA
RELL
Price
$0.57
$20.08
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$3.25
★ $25.50
AVG Volume (30 Days)
★ 9.5M
249.2K
Earning Date
11-05-2026
10-07-2026
Dividend Yield
N/A
★ 1.25%
EPS Growth
★ 93.94
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $228,564,000.00
Revenue This Year
N/A
$12.68
Revenue Next Year
N/A
$9.21
P/E Ratio
★ N/A
$230.96
Revenue Growth
N/A
★ 9.41
52 Week Low
$0.36
$9.37
52 Week High
$1.84
$23.15

Technical Indicators

Market Signals
Indicator
AKBA
RELL
Relative Strength Index (RSI) 41.52 54.26
Support Level $0.54 $15.40
Resistance Level $1.00 $21.50
Average True Range (ATR) 0.07 1.35
MACD -0.01 -0.05
Stochastic Oscillator 45.81 77.21

Price Performance

Historical Comparison
AKBA
RELL

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd is a world-wide manufacturer of engineered solutions, green energy products, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components including green energy solutions; tubes for diagnostic imaging equipment; and customized display solutions. It serve customers in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. Its products and services include design-in support, systems integration, prototype design and manufacturing, testing, logistics, etc. Its segments are Power and Microwave Technologies (PMT), Green Energy Solutions (GES), and Canvys. Majority of Sales is from PMT. Majority of sales is from North America.

Share on Social Networks: